Suppression of rds Expression by siRNA and Gene Replacement Strategies for Gene Therapy Using rAAV Vector
Open accessThe DOI matches its Crossref record.
Abstract
Small interfering RNA (siRNA) is a promising tool for the treatment of dominant diseases. Autosomal dominant eye disease like retinitis pigmentosa, are a leading cause of blindness. Mutations in rds/peripherin lead to the degeneration of photoreceptors and are associated with several autosomal retinal diseases. Our goal is to develop a gene therapy for rds mutations. We describe a siRNA based mutation-independent approach, targeting rds in which levels of endogenous mutant and wild-type mRNA were reduced, and a siRNA-resistant version of rds gene was supplied simultaneously. siRNAs and resistant rds were delivered to the photoreceptors by recombinant adeno-associated virus (rAAV) vector through subretinal injections. The retinal phenotype was examined, both structurally and functionally at different time points after rAAV delivery. We demonstrate suppression of rds transcript by up to 50% with concomitant expression of replacement transcript in the retina of mice in vivo. These results validate the concept of suppression of rds and replacement strategies of gene therapy with rAAV vectors containing siRNA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Gene Therapy in Retinal Dystrophies
Ziccardi, L., Cordeddu, V., Gaddini, L., Matteucci, A., Parravano, M., Malchiodi-Albedi, F., & Varano, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225722 · Cited by 107
Immunology of AAV-Mediated Gene Transfer in the Eye
Willett, K., & Bennett, J. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00261 · Cited by 105
“This approach is being studied in mutations of rhodopsin (46, 47) and rds/peripherin (48).”
BackgroundYe, G.-J., Budzynski, E., Sonnentag, P., Miller, P. E., Sharma, A. K., Ver Hoeve, J. N., Howard, K., Knop, D. R., Neuringer, M., McGill, T., et al. (2015) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2015.076 · Cited by 53
“Additionally, intravitreal injection of AAV2-GFP vectors packaged in capsids with multiple YF mutations achieved GFP expression in the ganglion, Müller, and inner retinal cells.(18) Based on these observations, in a preliminary study we evaluated intravitreal injection inrhesus macaques of AAV vectors expressing eithe…”
Non-viral therapeutic approaches to ocular diseases: An overview and future directions
Zulliger, R., Conley, S. M., & Naash, M. I. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.007 · Cited by 50
Daich Varela, M., Georgiadis, A., & Michaelides, M. (2023) · British Journal of Ophthalmology · doi:10.1136/bjo-2022-321903 · Cited by 30
Metadata
- Authors
- Petrs-Silva, H., Yasumura, D., Matthes, M. T., LaVail, M. M., Lewin, A. S., & Hauswirth, W. W.
- Venue
- Advances in Experimental Medicine and Biology
- Publisher
- Springer US
- Published
- 2011-11-11
- Volume
- 723
- Pages
- 215-223
- ISSN
- 0065-2598 (ISSN-L)
- OpenAlex
- W48330776
- Cited by
- 26
- References
- 0
- FWCI
- 3.73
- Type
- book chapter
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Suppression of rds Expression by siRNA and Gene Replacement Strategies for Gene Therapy Using rAAV Vector. https://app.cochat.ai/papers/10.1007/978-1-4614-0631-0_29
- The paper
- Petrs-Silva, H., Yasumura, D., Matthes, M. T., LaVail, M. M., Lewin, A. S., & Hauswirth, W. W. (2012). Suppression of rds Expression by siRNA and Gene Replacement Strategies for Gene Therapy Using rAAV Vector. Advances in Experimental Medicine and Biology. https://doi.org/10.1007/978-1-4614-0631-0_29
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.